USFDA completes inspection at API manufacturing facility of Aurobindo Pharma’s arm

18 Dec 2024 Evaluate

The United States Food and Drug Administration (USFDA) has completed inspection at Unit-V, an API manufacturing facility of Apitoria Pharma, a wholly owned subsidiary of Aurobindo Pharma, situated at Pashamylaram Village, Patancheru Mandal, Sanga Reddy District, Telangana. The inspection conducted from December 09, 2024 to December 17, 2024. The inspection closed with 02 observations. The observations are of procedural in nature and will be responded to within the stipulated time.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×